Conference paper
NEUROPSYCHOPHARMACOLOGY, vol. 44, NATURE PUBLISHING GROUP MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, 2019, pp. 432--432
APA
Click to copy
Nasca, C., Bigio, B., Dobbin, J., Lin, K. W., de Angelis, P., Myoraku, A., … others. (2019). Novel Mechanisms of Brain-Insulin Resistance in Patients With Major Depression and Acetylcarnitine Deficiency: An in-Vivo Study With the Exosomes Nanotechnology. In NEUROPSYCHOPHARMACOLOGY (Vol. 44, pp. 432–432). NATURE PUBLISHING GROUP MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND.
Chicago/Turabian
Click to copy
Nasca, Carla, Benedetta Bigio, Josh Dobbin, Katie Watson Lin, Paolo de Angelis, Alison Myoraku, Marin Kautz, et al. “Novel Mechanisms of Brain-Insulin Resistance in Patients With Major Depression and Acetylcarnitine Deficiency: An in-Vivo Study With the Exosomes Nanotechnology.” In NEUROPSYCHOPHARMACOLOGY, 44:432–432. NATURE PUBLISHING GROUP MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, 2019.
MLA
Click to copy
Nasca, Carla, et al. “Novel Mechanisms of Brain-Insulin Resistance in Patients With Major Depression and Acetylcarnitine Deficiency: An in-Vivo Study With the Exosomes Nanotechnology.” NEUROPSYCHOPHARMACOLOGY, vol. 44, NATURE PUBLISHING GROUP MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, 2019, pp. 432–32.
BibTeX Click to copy
@inproceedings{nasca2019a,
title = {Novel Mechanisms of Brain-Insulin Resistance in Patients With Major Depression and Acetylcarnitine Deficiency: An in-Vivo Study With the Exosomes Nanotechnology},
year = {2019},
organization = {NATURE PUBLISHING GROUP MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
pages = {432--432},
volume = {44},
author = {Nasca, Carla and Bigio, Benedetta and Dobbin, Josh and Lin, Katie Watson and de Angelis, Paolo and Myoraku, Alison and Kautz, Marin and Cochran, Ashly and Kocsis, James and Mathe, Aleksander and others},
booktitle = {NEUROPSYCHOPHARMACOLOGY}
}